Our Services

We deliver end‑to‑end life‑sciences innovation services spanning discovery, pre‑clinical development, clinical research, and commercialization, integrating deep expertise in biologics, vaccines, diagnostics, and advanced therapeutics with cutting‑edge computational biology, multi‑omics, and AI/ML‑driven analytics; our capabilities include target and biomarker discovery, protein science, assay and bioanalytical development, pre‑clinical and IND‑enabling support, CRAMS and central laboratory services, Phase I–IV clinical development and trial management, regulatory and global submission support, and downstream commercialization readiness, all executed through robust digital, modeling, and advanced computing platforms and delivered under stringent GMP, GLP, GCP, and GCLP quality and regulatory frameworks to accelerate translation from concept to clinic and market.

Antibodies II Bispecifics II Fusion Proteins II Recombinant Proteins II Protein Therapeutics

Scientists collaborating over advanced computational models in a modern lab.
Scientists collaborating over advanced computational models in a modern lab.
Close-up of AI-driven data analysis on a digital screen in a research facility.
Close-up of AI-driven data analysis on a digital screen in a research facility.
Discovery & Translational Research
  • Biologics and biomarker discovery, verification, and validation

  • Protein science, enzyme kinetics, binding affinity and speficity

  • Assay development and analytical method validation

  • Bioinformatics, systems biology, genomics, proteomics, and multi‑omics platforms

  • AI/ML powered simulation, discovery and development platform

  • Discovery to IND enabling and precision medicine strategies.

Clinical Development & Trial Management
  • Phase I–IV clinical trial support

  • Study design and protocol development

  • Site management, monitoring, and quality assurance

  • Clinical and translational laboratory services

  • Data management and clinical analytics

  • Bioavailability, bioequivalence, and pharmacokinetic studies

  • Regulatory affairs and global submission support (IND, NDA, BLA, CTA, etc.)

  • Quality & Compliance

Integrated Pre‑Clinical Research & Development
  • Disease biology and mechanism‑of‑action studies

  • Biochemical and immunological characterization

  • Bioanalytical assay development

  • Analytical method development and validation

  • Potency, binding, and functional assays

  • Immunogenicity assay

  • Pre‑Clinical Bioanalytics

  • Pre‑IND and IND‑enabling study support

  • Genomics, proteomics, and multi‑omics analysis

  • AI/ML‑enabled data analysis for pre‑clinical decision making

Contract Research & Manufacturing Services
  • Central laboratory and bioanalytical services

  • Biologics, vaccines, monoclonal antibodies, recombinant proteins, and biosimilars

  • Cell and gene therapy support

  • Product and process development

  • Formulation, delivery systems, and stability studies

  • Immunogenicity testing and comparability studies

  • Sample management and cold‑chain logistics

  • Formulation & Development Support

  • GMP, GLP, GCP, and GCLP‑compliant operations

Our Work

Scientists collaborating over advanced computational models in a bright lab.
Scientists collaborating over advanced computational models in a bright lab.
Discovery Phase

Our innovative platform provide deep insight on drug-target affinity and kinetics and removes development risk early on

Close-up of a researcher analyzing molecular structures on a digital screen.
Close-up of a researcher analyzing molecular structures on a digital screen.
Clinical Support

Our team guides clinical trials design and plan with data-driven AI/ML powered insights, ensuring reduction of molecular level risks in translation from lab discoveries to patient-ready therapies.

Pre-Clinical Phase

We dive deep into protein science, disease biology, using innovative platform and AI and machine learning to uncover new biologic targets and accelerate early-stage research with precision and speed.

Contract Research & Manufacturing Services

Expert Team Solving the Toughest Biologic Development and Manufacturing Challenges

Bridging science and innovation seamlessly

At Proteo Quant, better biologics decisions start with deeper molecular insight

Biologics programs with data of micro-second level affinity and functional readouts

Proteo Quant helps uncover what standard screening misses:

  • mechanistic binding behavior

  • transient interaction kinetics

  • early developability liabilities

  • molecular stability risks

  • candidate comparability differences

Kinetic Intelligence: Data Beyond Kd

  • kon

  • koff

  • residence time

  • transient binding phases

  • mechanistic binding models

Developability Intelligence: Early risk assessment across

  • aggregation

  • self-interaction

  • thermal stability

  • colloidal stability

Analytical Characterization: Build molecular confidence through

  • purity assessment

  • heterogeneity analysis

  • stability characterization

  • comparability profiling

Get in Touch

Reach out to bionexis for tailored support on your biologics and vaccine projects.

P

+1-555-789-4321

E

contact@bionexis.com